A 43-year-old member asked:
Can you suggest any alternative methods to treating hodgkin's lymphoma patients who respond negatively to avbd treatment?
3 doctor answers • 5 doctors weighed in
Hematology and Oncology 24 years experience
3.9k viewsAnswered >2 years ago
Medical Oncology 32 years experience
3.3k viewsReviewed >2 years ago
Medical Oncology 26 years experience
Adcetris (brentuximab vedotin) / Nivolumab: There are several classes of drugs that offer good options for patients with Hodgkin lymphoma who have not responded to ABVD. The standard of care in a younger patient is intensive salvage chemotherapy and stem cell transplant. Other options would include Brentuximab or a PD1 inhibitor such as Nivolumab or Pembrolizumab.
Created for people with ongoing healthcare needs but benefits everyone.
3k viewsReviewed >2 years ago
Last updated Jan 25, 2020
Connect with a U.S. board-certified doctor by text or video anytime, anywhere.
24/7 visits - just $39!
50% off with $15/month membership
Content on HealthTap (including answers) should not be used for medical advice, diagnosis, or treatment, and interactions on HealthTap do not create a doctor-patient relationship. Never disregard or delay professional medical advice in person because of anything on HealthTap. Call your doctor or 911 if you think you may have a medical emergency.